Showing results (771-780 of 1,169) with videos related to

Sort By:
Pageof 117
Current Oncology (Toronto, Ont.)|February 25, 2025
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic CholangiocarcinomaDai Zhang, Bao-Ye Sun, Jing-Fang Wu, et al.
Hepatology (Baltimore, Md.)|December 26, 2024
LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinomaRongqi Sun, Kaixuan Liu, Siyuan Pan, et al.
Plos One|October 1, 2011
Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinomaRanjan Prasad Devbhandari, Guo-Ming Shi, Ai-Wu Ke, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 11, 2014
High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinomaWei-Ren Liu, Meng-Xin Tian, Lei Jin, et al.
Clinical and Translational Medicine|May 28, 2021
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2Dan Yin, Zhi-Qiang Hu, Chu-Bin Luo, et al.
Biomarker Research|January 13, 2025
The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapyTian He, Bin Xu, Lu-Na Wang, et al.
Journal of Cancer|November 3, 2021
Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinomaFei Song, Fei-Yu Chen, Sui-Yi Wu, et al.
Gut|May 6, 2010
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinomaXin-Rong Yang, Yang Xu, Bin Yu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 26, 2014
Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluidsJia Fan, Shiwen Niu, Ailian Dong, et al.
Hepatology International|April 28, 2023
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1Jie Hu, Wei-Feng Liu, Xiang-Yu Zhang, et al.
Pageof 117